Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tarsus Pharmaceuticals (TARS) Research & Development: 2020-2024

Historic Research & Development for Tarsus Pharmaceuticals (TARS) over the last 5 years, with Dec 2024 value amounting to $53.4 million.

  • Tarsus Pharmaceuticals' Research & Development rose 34.27% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.2 million, marking a year-over-year increase of 26.78%. This contributed to the annual value of $53.4 million for FY2024, which is 6.11% up from last year.
  • As of FY2024, Tarsus Pharmaceuticals' Research & Development stood at $53.4 million, which was up 6.11% from $50.3 million recorded in FY2023.
  • Tarsus Pharmaceuticals' 5-year Research & Development high stood at $53.4 million for FY2024, and its period low was $18.8 million during FY2020.
  • Its 3-year average for Research & Development is $48.8 million, with a median of $50.3 million in 2023.
  • Data for Tarsus Pharmaceuticals' Research & Development shows a peak YoY surged of 121.57% (in 2021) over the last 5 years.
  • Tarsus Pharmaceuticals' Research & Development (Yearly) stood at $18.8 million in 2020, then soared by 121.57% to $41.7 million in 2021, then grew by 2.19% to $42.6 million in 2022, then climbed by 18.04% to $50.3 million in 2023, then climbed by 6.11% to $53.4 million in 2024.